Shenzhen Lifotronic Technology Co., Ltd. (SHA:688389)

SHA:688389 Revenue

Shenzhen Lifotronic Technology had revenue of 325.43M CNY in the quarter ending September 30, 2026, with 27.11% growth. This brings the company's total for the last twelve months to 1.20B, up 14.25% year-over-year. In the year 2025, Shenzhen Lifotronic Technology had annual revenue of 1.04B, down -9.60%. That makes Shenzhen Lifotronic Technology the 18,219th largest company in the world by revenue and 3,326th in China.

• Revenue (ttm): 1.20B
• Revenue Growth: +14.25%
• P/S Ratio: 3.96
• Revenue / Employee: 635.18K
• Employees: 1,896
• Market Cap: 4.76B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• in Vitro Diagnostics - Test Reagents 528.40M 50.9%
• in Vitro Diagnostics - Inspection Equipment 249.37M 24.0%
• Treatment and Rehabilitation - Medical Products 181.72M 17.5%
• Treatment and Rehabilitation - Home Products 56.20M 5.4%
• Unallocated Others 22.14M 2.1%

By Geography

Chart

• China 601.96M 58.0%
• Overseas 435.87M 42.0%

Fiscal year ended Dec 31, 2025 See the full SHA:688389 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.04B	-110.21M	-9.60%
Dec 31, 2024	1.15B	2.32M	0.20%
Dec 31, 2023	1.15B	162.67M	16.55%
Dec 31, 2022	983.04M	204.94M	26.34%
Dec 31, 2021	778.11M	224.28M	40.50%

Data Source: S&P Global Market Intelligence Last updated: Oct 29, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error